SCHAUMBURG, Ill.--(BUSINESS WIRE)--Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that it has filed its Form 10-Q with the Securities and Exchange Commission. APP Pharmaceuticals, Inc., which was acquired by Fresenius Kabi Pharmaceuticals Holding, Inc., is a member of the Fresenius Kabi Group. The Form 10-Q details the Company’s unaudited financial statements for the quarter ending September 30, 2010.
